Co-Diagnostics, Inc. 10-K

ITEM 5. MARKET FOR REGISTRANT’S COMMON EQUITY, RELATED STOCKHOLDER MATTERS AND ISSUER EQUITY SECURITIES Market Information Our common stock has been quoted on the NASDAQ market under the symbol “CODX” since July 12, 2017. The following table sets forth the high and low prices for our common stock for the periods indicated, as reported by NASDAQ. Calendar Quarter Ended: High Low March 31, 2021 $ 20.69 $ 7.86 June 30, 2021 $ 9.91 $ 7.01 September 30, 2021 $ 11.82 $ 7.35 December 31, 2021 $ 10.90 $ 7.90 Calendar Quarter Ended: High Low March 31, 2020 $ 21.75 $ 0.88 June 30, 2020 $ 29.72 $ 6.81 September 30, 2020 $ 30.99 $ 8.07 December 31, 2020 $ 16.96 $ 9.01 Holders As of March 22, 2022, the last reported sales price reported on NASDAQ for our common stock was $6.47 per share. As of March 22, 2022, we had approximately 154 record holders of our common stock. The number of record holders was determined from the records of our transfer agent and does not include beneficial owners of common stock whose shares are held in the names of various security brokers, dealers, and registered clearing agencies. The transfer agent for our common stock is VStock Transfer LLC located at 18 Lafayette Pl, Woodmere, New York 11598. 17 Dividends We have never declared or paid any cash dividends on our capital stock. The payment of dividends on our common stock in the future will depend on our earnings, capital requirements, operating and financial condition and such other factors as our Board of Directors may consider appropriate. We do not anticipate paying dividends on our common stock in the foreseeable future. Recent Sales of Unregistered Securities We issued the unregistered securities below. For the issuances of unregistered securities, we relied on the exemption from registration requirements of the Securities Act of 1933, as amended, available under Section 4(a)(2) promulgated thereunder due to the fact that such issuances did not involve a public offering of securities. ● During the year ended December 31, 2021, we issued an aggregate of 5,548 shares of our common stock for services rendered pursuant to consulting agreements. Purchases of Equity Securities by the Issuer and Affiliated Purchasers None. ITEM 6. RESERVED